Vanguard Group’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
1,118,226
-139,964
| -11% | -$175K | ﹤0.01% | 3653 |
|
|
2025
Q1 | $4.06M | Sell |
1,258,190
-10,564
| -0.8% | -$34.1K | ﹤0.01% | 3251 |
|
|
2024
Q4 | $5.23M | Buy |
1,268,754
+117,227
| +10% | +$483K | ﹤0.01% | 3249 |
|
|
2024
Q3 | $7.39M | Buy |
1,151,527
+1,122,847
| +3,915% | +$7.21M | ﹤0.01% | 3105 |
|
|
2024
Q2 | $138K | Buy |
+28,680
| New | +$138K | ﹤0.01% | 4201 |
|